2-D DIGE analyses of enriched secretory lysosomes reveal heterogeneous profiles of functionally relevant proteins in leukemic and activated human NK cells

Proteomics

Volumn 8, Issue 14, 2008, Pages 2911-2925

  Schmidt, Hendrik ^a   Gelhaus, Christoph ^b   Nebendahl, Melanie ^a   Lettau, Marcus ^a   Watzl, Carsten ^c   Kabelitz, Dieter ^a   Leippe, Matthias ^b   Janssen, Ottmar ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

2 D DIGE; Immunology; NK cells; Secretory lysosome

Indexed keywords

PROTEOME;

ANTIGEN PRESENTATION; ARTICLE; CELL FRACTIONATION; CELL POPULATION; CONTROLLED STUDY; CYTOTOXICITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LEUKEMIA CELL; LYSOSOME; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TWO DIMENSIONAL GEL ELECTROPHORESIS;

CELL LINE, TRANSFORMED; CELL LINE, TUMOR; CELLS, CULTURED; CYTOTOXICITY, IMMUNOLOGIC; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HUMANS; IMMUNOPHENOTYPING; KILLER CELLS, NATURAL; LEUKEMIA; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBSETS; LYSOSOMES; NEOPLASM PROTEINS; TUMOR MARKERS, BIOLOGICAL;

EID: 48949087726     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.200800170     Document Type: Article

References (52)

1. Clark, R., Griffiths, G. M., Lytic granules, secretory lysosomes and disease. Curr. Opin. Immunol. 2003, 15, 516-521.
2. Blott, E. J., Griffiths, G. M., Secretory lysosomes. Nat. Rev. Mol. Cell Biol. 2002, 3, 122-131.
3. Bossi, G., Griffiths, G. M., Degranulation plays an essential part in regulating cell surface expression of Fas ligand in T cells and natural killer cells. Nat. Med. 1999, 5, 90-96.
4. Lettau, M., Qian, J., Linkermann, A., Latreille, M. et al., The adaptor protein Nck interacts with Fas ligand: Guiding the death factor to the cytotoxic immunological synapse. Proc. Natl. Acad. Sci. USA 2006, 103, 5911-5916.
5. Bossi, G., Trambas, C., Booth, S., Clark, R. et al., The secretory synapse: the secrets of a serial killer. Immunol. Rev. 2002, 189, 152-160.
6. Burkhardt, J. K., Wiebel, F. A., Hester, S., Argon, Y., The giant organelles in beige and Chediak-Higashi fibroblasts are derived from late endosomes and mature lysosomes. J. Exp. Med. 1993, 178, 1845-1856.
7. Shiflett, S. L., Kaplan, J., Ward, D. M., Chediak-Higashi Syndrome: a rare disorder of lysosomes and lysosome related organelles. Pigment Cell Res. 2002, 15, 251-257.
8. Ward, D. M., Griffiths, G. M., Stinchcombe, J. C., Kaplan, J., Analysis of the lysosomal storage disease Chediak-Higashi syndrome. Traffic 2000, 1, 816-822.
9. Kaplan, J., De, D., I, Ward, D. M., Chediak-Higashi syndrome. Curr. Opin. Hematol. 2008, 15, 22-29.
10. Baum, W., Kirkin, V., Fernandez, S. B., Pick, R. et al., Binding of the intracellular Fas ligand (FasL) domain to the adaptor protein PSTPIP results in a cytoplasmic localization of FasL. J. Biol. Chem. 2005, 280, 40012-40024.
11. Chen, X., Allan, D. S., Krzewski, K., Ge, B. et al., CD28-stimulated ERK2 phosphorylation is required for polarization of the microtubule organizing center and granules in YTS NK cells. Proc. Natl. Acad. Sci. USA 2006, 103, 10346-10351.
12. Chen, X., Trivedi, P. P., Ge, B., Krzewski, K. et al., Many NK cell receptors activate ERK2 and JNK1 to trigger microtubule organizing center and granule polarization and cytotoxicity. Proc. Natl. Acad. Sci. USA 2007, 104, 6329-6334.
13. Casey, T. M., Meade, J. L., Hewitt, E. W., Organelle proteomics: identification of the exocytic machinery associated with the natural killer cell secretory lysosome. Mol. Cell Proteomics 2007, 6, 767-780.
14. Hanna, J., Fitchett, J., Rowe, T., Daniels, M. et al., Proteomic analysis of human natural killer cells: insights on new potential NK immune functions. Mol. Immunol. 2005, 42, 425-431.
15. Rabinowich, H., Sedlmayr, P., Herberman, R. B., Whiteside, T. L., Increased proliferation, lytic activity, and purity of human natural killer cells cocultured with mitogen-activated feeder cells. Cell Immunol. 1991, 135, 454-470.
16. Robertson, M. J., Cochran, K. J., Cameron, C., Le, J. M. et al., Characterization of a cell line, NKL, derived from an aggressive human natural killer cell leukemia. Exp. Hematol. 1996, 24, 406-415.
17. Yodoi, J., Teshigawara, K., Nikaido, T., Fukui, K. et al., TCGF (IL 2)-receptor inducing factor(s). I. Regulation of IL 2 receptor on a natural killer-like cell line (YT cells). J. Immunol. 1985, 134, 1623-1630.
18. O'Farrell, P. H., High resolution two-dimensional electrophoresis of proteins. J. Biol. Chem. 1975, 250, 4007-4021.
19. Tonge, R., Shaw, J., Middleton, B., Rowlinson, R. et al., Validation and development of fluorescence two-dimensional differential gel electrophoresis proteomics technology. Proteomics 2001, 1, 377-396.
20. Gelhaus, C., Fritsch, J., Krause, E., Leippe, M., Fractionation and identification of proteins by 2-DE and MS: towards a proteomic analysis of Plasmodium falciparum. Proteomics 2005, 5, 4213-4222.
21. Hu, Z. Z., Valencia, J. C., Huang, H., Chi, A. et al., Comparative Bioinformatics Analyses and Profiling of Lysosome-Related Organelle Proteomes. Int. J. Mass Spectrom. 2007, 259, 147-160.
22. Hoffmann, R., Valencia, A., A gene network for navigating the literature. Nat. Genet. 2004, 36, 664.
23. Bania, J., Gatti, E., Lelouard, H., David, A. et al., Human cathepsin S, but not cathepsin L, degrades efficiently MHC class II-associated invariant chain in nonprofessional APCs. Proc. Natl. Acad. Sci. USA 2003, 100, 6664-6669.
24. Basrur, V., Yang, F., Kushimoto, T., Higashimoto, Y. et al., Proteomic analysis of early melanosomes: identification of novel melanosomal proteins. J. Proteome. Res. 2003, 2, 69-79.
25. Chi, A., Valencia, J. C., Hu, Z. Z., Watabe, H. et al., Proteomic and bioinformatic characterization of the biogenesis and function of melanosomes. J. Proteome. Res. 2006, 5, 3135-3144.
26. Masson, D., Peters, P. J., Geuze, H. J., Borst, J. et al., Interaction of chondroitin sulfate with perforin and granzymes of cytolytic T-cells is dependent on pH. Biochemistry 1990, 29, 11229-11235.
27. Raja, S. M., Wang, B., Dantuluri, M., Desai, U. R. et al., Cytotoxic cell granule-mediated apoptosis. Characterization of the macromolecular complex of granzyme B with serglycin. J. Biol. Chem. 2002, 277, 49523-49530.
28. Darmon, A. J., Nicholson, D. W., Bleackley, R. C., Activation of the apoptotic protease CPP32 by cytotoxic T-cell-derived granzyme B. Nature 1995, 377, 446-448.
29. Lettau, M., Schmidt, H., Kabelitz, D., Janssen, O., Secretory lysosomes and their cargo in T and NK cells. Immunol. Lett. 2007, 108, 10-19.
30. Lieberman, J., The ABCs of granule-mediated cytotoxicity: new weapons in the arsenal. Nat. Rev. Immunol. 2003, 3, 361-370.
31. Ko, Y. H., Park, S., Jin, H., Woo, H. et al., Granzyme B leakage-induced apoptosis is a crucial mechanism of cell death in nasal-type NK/T-cell lymphoma. Lab Invest 2007, 87, 241-250.
32. Mahrus, S., Craik, C. S., Selective chemical functional probes of granzymes A and B reveal granzyme B is a major effector of natural killer cell-mediated lysis of target cells. Chem. Biol. 2005, 12, 567-577.
33. Pipkin, M. E., Lieberman, J., Delivering the kiss of death: progress on understanding how perforin works. Curr. Opin. Immunol. 2007, 19, 301-308.
34. Hanna, J., Gonen-Gross, T., Fitchett, J., Rowe, T. et al., Novel APC-like properties of human NK cells directly regulate T cell activation. J. Clin. Invest 2004, 114, 1612-1623.
35. Raposo, G., Tenza, D., Mecheri, S., Peronet, R. et al., Accumulation of major histocompatibility complex class II molecules in mast cell secretory granules and their release upon degranulation. Mol. Biol. Cell 1997, 8, 2631-2645.
36. Vincent-Schneider, H., Thery, C., Mazzeo, D., Tenza, D. et al., Secretory granules of mast cells accumulate mature and immature MHC class II molecules. J. Cell Sci. 2001, 114, 323-334.
37. Riese, R. J., Mitchell, R. N., Villadangos, J. A., Shi, G. P. et al., Cathepsin S activity regulates antigen presentation and immunity. J. Clin. Invest. 1998, 101, 2351-2363.
38. Shi, G. P., Villadangos, J. A., Dranoff, G., Small, C. et al., Cathepsin S required for normal MHC class II peptide loading and germinal center development. Immunity 1999, 10, 197-206.
39. Mangeat, P., Roy, C., Martin, M., ERM proteins in cell adhesion and membrane dynamics. Trends Cell Biol. 1999, 9, 187-192.
40. Tsukita, S., Yonemura, S., Cortical actin organization: lessons from ERM (ezrin/radixin/moesin) proteins. J. Biol. Chem. 1999, 274, 34507-34510.
41. Bretscher, A., Chambers, D., Nguyen, R., Reczek, D., ERM-Merlin and EBP50 protein families in plasma membrane organization and function. Annu. Rev. Cell Dev. Biol. 2000, 16, 113-143.
42. Delon, J., Kaibuchi, K., Germain, R. N., Exclusion of CD43 from the immunological synapse is mediated by phosphorylation-regulated relocation of the cytoskeletal adaptor moesin. Immunity 2001, 15, 691-701.
43. Faure, S., Salazar-Fontana, L. I., Semichon, M., Tybulewicz, V. L. et al., ERM proteins regulate cytoskeleton relaxation promoting T cell-APC conjugation. Nat. Immunol. 2004, 5, 272-279.
44. Cooley, J., Takayama, T. K., Shapiro, S. D., Schechter, N. M. et al., The serpin MNEI inhibits elastase-like and chymotrypsin-like serine proteases through efficient reactions at two active sites. Biochemistry 2001, 40, 15762-15770.
45. Ottonello, L., Epstein, A. L., Mancini, M., Dapino, P. et al., Monoclonal LYM-1 antibody-dependent cytolysis by human neutrophils exposed to GM-CSF: auto-regulation of target cell attack by cathepsin G. J. Leukoc. Biol. 2004, 75, 99-105.
46. Yamazaki, T., Aoki, Y., Cathepsin G binds to human lymphocytes. J. Leukoc. Biol. 1997, 61, 73-79.
47. Yamazaki, T., Aoki, Y., Cathepsin G enhances human natural killer cytotoxicity. Immunology 1998, 93, 115-121.
48. Bots, M., VAN, B. L., Rademaker, M. T., Offringa, R. et al., Serpins prevent granzyme-induced death in a species-specific manner. Immunol. Cell Biol. 2006, 84, 79-86.
49. Sun, J., Bird, C. H., Sutton, V., McDonald, L. et al., A cytosolic granzyme B inhibitor related to the viral apoptotic regulator cytokine response modifier A is present in cytotoxic lymphocytes. J. Biol. Chem. 1996, 271, 27802-27809.
50. Bird, C. H., Blink, E. J., Hirst, C. E., Buzza, M. S. et al., Nucleocytoplasmic distribution of the ovalbumin serpin PI-9 requires a nonconventional nuclear import pathway and the export factor Crm1. Mol. Cell Biol. 2001, 21, 5396-5407.
51. Bird, C. H., Sutton, V. R., Sun, J., Hirst, C. E. et al., Selective regulation of apoptosis: the cytotoxic lymphocyte serpin proteinase inhibitor 9 protects against granzyme B-mediated apoptosis without perturbing the Fas cell death pathway. Mol. Cell Biol. 1998, 18, 6387-6398.
52. Hirst, C. E., Buzza, M. S., Bird, C. H., Warren, H. S. et al., The intracellular granzyme B inhibitor, proteinase inhibitor 9, is up-regulated during accessory cell maturation and effector cell degranulation, and its overexpression enhances CTL potency. J. Immunol. 2003, 170, 805-815.